Daniel Kaplan Quoted on Omicron’s Impact on Employers
16 January 2022
The American City Business Journals
Partner Daniel (Dan) Kaplan was quoted in an article in The American City Business Journals titled “Omicron sharpens labor pains for short-staffed businesses” that discusses how the Omicron variant is currently challenging employers by way of staffing shortages.
Kaplan shared that his clients are seeing considerably more absences, which is leading to more mask requirements and additional encouragement to be vaccinated. He added, “Employers need employees. If employees quit because they are mandated to get a vaccination — that is not good for employers. Similarly, if employees are ill because they are unvaccinated and therefore out of the workforce, even temporarily, that too is bad for employers.”
People
Related News
06 September 2024
In the News
Old Employment Law Principles Can Answer New AI Concerns
The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.
06 September 2024
In the News
Nathaniel Lacktman, Foley's 50-State Survey of Telehealth Insurance Laws Highlighted for Guidance on Legal Landscape
Foley & Lardner LLP partner Nathaniel Lacktman, chair of the firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, discussed telehealth reimbursement parity, exclusivity contracts, and remote patient monitoring in the Managed Healthcare Executive article, “Telehealth is a Go, and States Are Having Their Say So.”
05 September 2024
In the News
Nathaniel Lacktman on Potential DEA Telemedicine Prescribing Crackdown – 'It's putting doctors in a really difficult situation'
Foley & Lardner LLP partner Nathaniel Lacktman, chair of firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, discussed the potential consequences of the U.S. Drug Enforcement Agency enacting regressive regulations on telemedicine prescribing in Endpoints News, a Financial Times publication.